The biguanide compound metformin prevents desensitization of human pancreatic islets induced by high glucose

European Journal of Pharmacology

Volumn 364, Issue 2-3, 1999, Pages 205-209

  Lupi, Roberto ^a   Del Guerra, Silvia ^a   Tellini, Cristina ^a   Giannarelli, Rosa ^a   Coppelli, Alberto ^a   Lorenzetti, Monica ^a   Carmellini, Mario ^b   Mosca, Franco ^b   Navalesi, Renzo ^a   Marchetti, Piero ^a  

^a CISANELLO HOSPITAL   (Italy)

^b UNIVERSITY OF PISA   (Italy)

Author keywords

Glucose desensitization; Glyburide; Metformin; Pancreatic islet

Indexed keywords

ARGININE; GLIBENCLAMIDE; GLUCOSE; METFORMIN; ORAL ANTIDIABETIC AGENT;

ARTICLE; DESENSITIZATION; DRUG EFFECT; FEMALE; HUMAN; HUMAN CELL; HUMAN TISSUE; HYPERGLYCEMIA; INSULIN RELEASE; LONG TERM EXPOSURE; MALE; PANCREAS ISLET; PRIORITY JOURNAL;

ADOLESCENT; ADULT; ARGININE; BIGUANIDES; CADAVER; DOSE-RESPONSE RELATIONSHIP, DRUG; FEMALE; GLUCOSE; GLYBURIDE; HUMANS; HYPOGLYCEMIC AGENTS; INSULIN; ISLETS OF LANGERHANS; MALE; METFORMIN; MIDDLE AGED;

EID: 0032921702     PISSN: 00142999     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0014-2999(98)00807-3     Document Type: Article

References (26)

1. Anello M., Rabuazzo A.M., Degano C., Caltabiano V., Patané G., Vigneri R., Purrello F. Fast reversibility of glucose-induced desensitization in rat pancreatic islets: evidence for an involvement of ionic fluxes. Diabetes. 45:1996;502-506.
2. Bailey C.J. Biguanides and NIDDM. Diabetes Care. 15:1992;755-772.
3. Bailey C.J. Metformin. New Engl. J. Med. 334:1996;574-579.
4. Best L., Yates A.P., Meats J.C., Tomlinson S. Effects of lactate on pancreatic islets: lactate efflux as a possible determinant of islet cell depolarization by glucose. Biochem. J. 259:1989;507-511.
5. Davalli A.M., Ricordi C., Socci C., Braghi S., Bertuzzi F., Fattor B., Di Carlo V., Pontiroli A.E., Pozza G. Abnormal sensitivity to glucose of human islets cultured in a high glucose medium: partial reversibility after an additional culture in a normal glucose medium. J. Clin. Endocrinol. Metab. 72:1991;202-208.
6. Davidoff F. Guanidine derivatives in medicine. New Engl. J. Med. 288:1973;141-146.
7. Dunn C.J., Peters D.H. Metformin: a review of its pharmacological properties and therapeutic use in non-insulin dependent diabetes mellitus. Drugs. 49:1995;721-749.
8. Eizirik D.L., Korbutt G.S., Hellerstrom C. Prolonged exposure of human pancreatic islets to high glucose concentrations in vitro impairs the B-cell function. J. Clin. Invest. 90:1992;1263-1268.
9. Gregorio F., Filipponi P., Ambrosi F., Cristallini S., Marchetti P., Calafiore R., Navalesi R., Brunetti P. Metformin potentiates B-cell response to high glucose: an in vitro study on isolated perfused pancreas from normal rats. Diabetes Metab. 15:1989;111-117.
10. Hermann L.S., Schertsen B., Bitzen P.O., Kjellestrom T., Lindgarde F., Melander A. Therapeutic comparison of metformin and sulfonylurea, alone and in various combination: a double-blind controlled study. Diabetes Care. 17:1994;1100-1109.
11. Marchetti P., Navalesi R. Pharmacokinetic-pharmacodynamic relationships of oral hypoglycemic agents. Clin. Pharmacokinet. 16:1989;100-128.
12. Marchetti P., Giannarelli R., Cosimi, Masiello P., Coppelli A., Viacava P., Navalesi R. Massive isolation, morphological and functional characterization and xenotransplantation of bovine pancreatic islets. Diabetes. 44:1995;375-381.
13. Marchetti P., Scharp D.W., Giannarelli R., Benzi L., Cecchetti P., Di Carlo A., Ciccarone A.M., Lacy P.E., Navalesi R. Metformin potentiates glucose-stimulated insulin secretion. Diabetes Care. 19:1996;612-613.
14. Marchetti P., Trincavelli L., Giannarelli R., Martini C., Lucacchini A., Cosimi S., Carmellini M., Mosca F., Navalesi R. Characterization of peripheral benzodiazepine receptors in purified large mammal pancreatic islets. Biochem. Pharmacol. 51:1996;1437-1442.
15. Marynissen G., Leclerq-Meyer V., Sener A., Malaisse W.J. Perturbation of pancreatic islet function in glucose-infused rats. Metab. Clin. Exp. 39:1990;87-95.
16. Purrello F., Vetri M., Gatta C., Gullo D., Vigneri R. Effects of high glucose on insulin secretion by isolated rat islets and purified B-cells and possible role of glycosylation. Diabetes. 38:1989;1417-1422.
17. Purrello F., Rabuazzo A.M., Anello M., Patanè G. Effects of prolonged glucose stimulation on pancreatic beta cells: from increased sensitivity to desensitization. Acta Diabetol. 33:1996;253-256.
18. Robertson R.P., Olson L.K., Zhang H.J. Differentiating glucose toxicity from glucose desensitization: a new message from the insulin gene. Diabetes. 43:1994;1085-1089.
19. Rossetti L., Giaccari A., DeFronzo R.A. Glucose toxicity. Diabetes Care. 13:1990;610-630.
20. Sako Y., Grill V.E. Coupling of B-cell desensitization by hyperglycemia to excessive stimulation and circulating insulin in glucose-infused rats. Diabetes. 39:1990;1580-1583.
21. Scheen A.J. Clinical pharmacokinetics of metformin. Clin. Pharmacokinet. 30:1996;359-371.
22. Scheen A.J., Lefebvre P.J. Oral antidiabetic agents: a guide to selection. Drugs. 55:1998;225-236.
23. Shah S., Malone J.I., Simpson N.E. A randomized trial of intensive insulin therapy in newly diagnosed insulin-dependent diabetes mellitus. New Engl. J. Med. 320:1989;550-554.
24. Unger R.H., Grundy S. Hyperglycemia as an inducer as well as a consequence of impaired islet cell function and insulin resistance: implications for the management of diabetes. Diabetologia. 28:1985;119-121.
25. Weir G.C., Lehay J.L., Bonner-Weir S. Experimental reduction of B-cell mass: implications for the pathogenesis of diabetes. Diabetes Metab. Rev. 2(125):1986;161.
26. Zawalich W.S., Zawalich K.C., Shulman G.I., Rossetti L. Chronic in vivo hyperglycemia impairs phosphoinositide hydrolysis and insulin release in isolated perfused islets. Endocrinology. 126:1990;253-260.